Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20.8M
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
48.8M
-
Shares change
-
+2.45M
-
Total reported value, excl. options
-
$266M
-
Value change
-
-$13.1M
-
Put/Call ratio
-
0.88
-
Number of buys
-
56
-
Number of sells
-
-41
-
Price
-
$5.45
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q3 2019
131 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q3 2019.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.8M shares
.
Largest 10 shareholders include RTW INVESTMENTS, LP (6.28M shares), STATE STREET CORP (4.84M shares), BlackRock Inc. (4.41M shares), Avoro Capital Advisors LLC (4.25M shares), ORBIMED ADVISORS LLC (4.01M shares), VANGUARD GROUP INC (2.74M shares), RENAISSANCE TECHNOLOGIES LLC (2.69M shares), UBS Group AG (2.28M shares), DIMENSIONAL FUND ADVISORS LP (2.15M shares), and Ghost Tree Capital, LLC (1.45M shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.